Nathan Hutchinson-Jones: Pharmacist-Led Care Optimises Cancer-Associated Thrombosis
Nathan Hutchinson-Jones, Deputy Chair – Trust Thrombosis and Haemostasis Group, shared a post on LinkedIn:
“A great day at the VTE Together conference in Dublin today, where I had the opportunity to talk about:
‘Beyond the prescription: What pharmacists really do in cancer-associated thrombosis (CAT)’
As CAT management has evolved, we now have more anticoagulant options and greater patient choice, but this has also made clinical decision making more complex.
My talk explored how pharmacists can add value beyond prescribing: navigating drug interactions and bleeding risk, supporting procedures, managing complex patients, providing education and safety netting, and helping deliver sustainable models of shared care.
I also shared our experience of developing a dedicated multidisciplinary CAT service at the RUH, where over one in four documented reviews resulted in optimisation of anticoagulant therapy.
None of this happens in isolation. Our service relies on close multidisciplinary working, with our specialist nursing team playing a central role in delivering the clinic, alongside pharmacy support.
For me, the future of CAT care is pharmacist enabled, multidisciplinary and patient centred.
I also think there is an opportunity for nationally endorsed, comprehensive guidance for CAT management, alongside wider adoption of dedicated multidisciplinary CAT clinics as the standard model of care.
Ultimately, it’s about the right anticoagulant, for the right patient, at the right time — with ongoing review throughout the cancer journey.
Thanks to Sarah Garvey and the VTE Together team for the invitation, and to my colleagues at the Royal United Hospitals Bath NHS Foundation Trust — particularly our specialist nursing team, RUH Pharmacy, Sinthiya Punnialingam , Uzo Ibechukwu and Nyasha Manomano — for their support in making this work possible.”
Stay updated with Hemostasis Today.
-
Nov 19, 2026, 16:27263 PolyU Students and Staff Unite to Donate Blood – Hong Kong Red Cross Blood Transfusion Service
-
Nov 19, 2026, 16:16Billy Otieno: The Future of Blood Donation Lies Beyond Collection
-
Nov 19, 2026, 15:58Hema Goyal: Hematocon 2026 Bringing Together Knowledge, Innovation and Excellence in Hematology
-
Nov 19, 2026, 15:44Chukwuemeka Amarachi: Understanding Complex Blood Grouping Beyond Routine ABO And RhD Typing
-
Nov 19, 2026, 14:19Long-Read Sequencing Is Closing Diagnostic Gaps in Inherited Bleeding Disorders
-
Nov 19, 2026, 13:36Raja Prince: Protein S Silencing and the Future of Hemostatic Therapy
-
Nov 19, 2026, 13:26M. Sekip Altunkan: The Thrombotic Risk of Andexanet Alfa
-
Nov 19, 2026, 13:18Felice Gragnano: Personalizing Antiplatelet Therapy After PCI
-
Nov 19, 2026, 13:11When Postpartum Warning Signs Are Ignored – National Blood Clot Alliance